Clinical Trials Directory

Trials / Completed

CompletedNCT03865095

Muscle Mass Loss in Critically Ill Patients.

Muscle Mass Loss in Critically Ill and Its Risk Factors. A Prospective Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Masaryk University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to describe the change in muscle mass in critically ill patients. The study will examine rectus femoris cross sectional area with ultrasound and identify risk factors of this changes.

Detailed description

The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our ICU from the 1st of March 2019 to the 31st of August 2019 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Ultrasound measurement of rectus femoris cross sectional area will be performed in first 24 hours after admission to ICU. Study data will be entered in study form. The ultrasound measurement will be repeated on day 7 of hospitalisation. Changes in rectus femoris cross sectional area and potential risk factors will be analysed. The length of ICU length of stay and 28-day mortality will be also monitored.

Conditions

Timeline

Start date
2019-03-25
Primary completion
2020-10-14
Completion
2020-11-14
First posted
2019-03-06
Last updated
2021-03-03

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT03865095. Inclusion in this directory is not an endorsement.

Muscle Mass Loss in Critically Ill Patients. (NCT03865095) · Clinical Trials Directory